Enhanced Aminos Back to Inventory
Cognitive

TSM

Targeted Synaptic Modulator

Dosage

10mg

Unit Size

1 Vial

What is TSM?

TSM (Targeted Synaptic Modulator) is a cognitive research peptide under investigation for its potential effects on synaptic function, neuroplasticity, and neurological signaling. It represents an emerging class of nootropic compounds studied for their capacity to influence brain activity, support neuroprotective pathways, and optimize cognitive performance in preclinical models.

10mg

Dose Per Vial

Synaptic

Primary Target

Cognitive

Research Category

Key Benefits

🧠

Cognitive Enhancement

Studied for potential improvements in cognitive performance, mental clarity, and information processing speed.

🔗

Synaptic Plasticity

Investigated for its effects on long-term potentiation and synaptic strengthening between neurons.

🛡️

Neuroprotection

Potential neuroprotective properties through modulation of neuroinflammatory and oxidative stress pathways.

📚

Memory & Learning

Research interest in TSM's effects on memory formation and learning pathways in preclinical models.

😊

Mood & Clarity

Explored for potential applications in mood regulation and mental clarity through neurotransmitter modulation.

⚡

Neuronal Energy

May support neuronal energy metabolism, addressing a key vulnerability in cognitive aging and neurodegeneration.

How It Works

1

Neurotransmitter System Modulation

TSM is hypothesized to interact with key neurotransmitter systems, modulating synaptic receptor activity and downstream neuronal signaling.

2

Neuroplasticity Support

Research focuses on TSM's potential to support synaptic plasticity mechanisms, including BDNF pathway engagement and LTP facilitation.

3

Blood-Brain Barrier Penetration

Current investigations are examining TSM's ability to cross the blood-brain barrier effectively and reach target neuronal populations.

4

Neuroinflammation Reduction

Preclinical research is examining TSM's potential to reduce microglial-mediated neuroinflammation, a key driver of cognitive decline.

Common Protocol (Research Reference)

10 mg

Dose per session

1×/day

Frequency

4–8 wks

Typical cycle length

Research Use Notice

TSM is a research peptide not approved by the FDA for human use. This information is for educational purposes only. Always consult a qualified healthcare professional before considering any peptide protocol.